Increased myeloid-derived suppressor cell activation in clonal cytopenia of undetermined significance and low-risk myelodysplastic syndrome
Publikation: Bidrag til tidsskrift › Letter › Forskning › fagfællebedømt
Standard
Increased myeloid-derived suppressor cell activation in clonal cytopenia of undetermined significance and low-risk myelodysplastic syndrome. / Bentivegna, Sofia; Côme, Christophe; Porse, Bo; Andersen, Mads Hald; Grønbæk, Kirsten.
I: British Journal of Haematology, 2024.Publikation: Bidrag til tidsskrift › Letter › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Increased myeloid-derived suppressor cell activation in clonal cytopenia of undetermined significance and low-risk myelodysplastic syndrome
AU - Bentivegna, Sofia
AU - Côme, Christophe
AU - Porse, Bo
AU - Andersen, Mads Hald
AU - Grønbæk, Kirsten
N1 - Funding Information: This project has received funding from the European Union\u2019s Horizon 2020 research and innovation programme under the Marie Sk\u0142odowska\u2010Curie grant agreement No 801481, the Greater Copenhagen Health Science Partners (Clinical Academic Group in Translational Hematology), and a centre grant from the Novo Nordisk Foundation (Novo Nordisk Foundation Center for Stem Cell Biology, DanStem; grant NNF17CC0027852). This project is also part of the Danish Research Center for Precision Medicine in Blood Cancers (Danish Cancer Society grant R223\u2010A13071).
PY - 2024
Y1 - 2024
N2 - Clonal cytopenia of undetermined significance (CCUS) is a condition characterized by the presence of persistent cytopenia in one or more blood cell lineages, accompanied by the detection of one or more somatic mutations associated with myeloid neoplasms in haematopoietic cells, with a variant allele frequency (VAF) of 2% or higher.1, 2 Patients with CCUS have an increased risk of developing myelodysplastic syndrome (MDS) or acute myeloid leukaemia. Numerous factors increase the risk of progression, including the VAF, the number and type of mutations.3-5 Several studies have highlighted molecular and clinical similarities between CCUS and low-risk MDS (LR-MDS) patients,6, 7 suggesting that CCUS represents an early manifestation of LR-MDS and underlining a biological continuum between these entities.
AB - Clonal cytopenia of undetermined significance (CCUS) is a condition characterized by the presence of persistent cytopenia in one or more blood cell lineages, accompanied by the detection of one or more somatic mutations associated with myeloid neoplasms in haematopoietic cells, with a variant allele frequency (VAF) of 2% or higher.1, 2 Patients with CCUS have an increased risk of developing myelodysplastic syndrome (MDS) or acute myeloid leukaemia. Numerous factors increase the risk of progression, including the VAF, the number and type of mutations.3-5 Several studies have highlighted molecular and clinical similarities between CCUS and low-risk MDS (LR-MDS) patients,6, 7 suggesting that CCUS represents an early manifestation of LR-MDS and underlining a biological continuum between these entities.
U2 - 10.1111/bjh.19609
DO - 10.1111/bjh.19609
M3 - Letter
AN - SCOPUS:85196558001
JO - British Journal of Haematology
JF - British Journal of Haematology
SN - 0007-1048
ER -
ID: 396640246